CRISPR/Cas9 vs. Tol2 Techniques for Zebrafish Genomic Manipulation

Evaluating Methods for Precision and Efficiency in Genetic Engineering

Genome editing in zebrafish has revolutionized the way researchers study gene function and model human diseases. Two of the most widely used techniques are CRISPR/Cas9 and Tol2 transgenesis. In this article, we will compare these two methods and discuss their advantages and disadvantages in zebrafish genome editing.

CRISPR/Cas9 Genome Editing

The CRISPR/Cas9 system, developed from a natural defense mechanism in bacteria, has revolutionized genome editing since its introduction. It allows for precise, targeted modifications of the DNA, making it a preferred method for many researchers.

CRISPR/Cas9 employs a guide RNA (gRNA) to direct the Cas9 enzyme to a specific DNA sequence. Once there, Cas9 induces a double-strand break (DSB). The cell's natural repair mechanisms, such as Non-Homologous End Joining (NHEJ) or Homology Directed Repair (HDR), then attempt to repair the break, often introducing mutations that can disrupt or modify gene function.

CRISPR/Cas9 technology can also be employed for knockin approaches. It can be used to introduce short or long DNA sequences serving different experimental purposes. Indeed, knockin strategies can be employed to generate single base changes (point mutations) causing precise small modifications in a protein sequence.

Advantages of CRISPR/Cas9

  • Specificity & Precision: CRISPR/Cas9 allows for highly specific targeting of genomic loci, reducing off-target effects compared to earlier technologies like TALENs and zinc-finger nucleases.
  • High Mutagenesis Efficiency: It can generate mutations rapidly, making it ideal for creating knockout models for any target gene of interest.
  • Versatility: The system can be used to edit multiple genes simultaneously, facilitating complex genetic studies.
  • Accessibility: A plethora of bioinformatics tools are available to design gRNAs, simplifying the implementation process.

Limitations of CRISPR/Cas9

  • Off-Target Effects: Despite its precision, CRISPR/Cas9 can sometimes target unintended sites, potentially causing unwanted mutations.
  • Unpredictable Mutation Sequences: Relying on the cell’s repair mechanisms, the CRISPR/Cas9 machinery generates mutations that are difficult to perfectly predict. Especially when NHEJ is involved, it is not possible to forecast the exact number of base pairs that will be deleted or inserted at the target site.
  • Challenging Knock-ins: Achieving precise knock-ins can be particularly challenging with CRISPR/Cas9. The efficiency of HDR, which is required for knock-ins, is generally low in zebrafish. This makes the process of inserting specific sequences or making precise modifications more difficult and less predictable compared to other methods. The larger the insert, the lower the integration efficiency.

Tol2 Transposase System

Tol2 is a DNA transposase originally discovered in the genome of the medaka fish. It has been widely adopted in zebrafish research as a tool for generating transgenic lines.

The Tol2 system relies on the co-injection of a plasmid containing the gene of interest flanked by Tol2 inverted terminal repeats (ITRs) and Tol2 transposase mRNA. The transposase enzyme recognizes the ITRs and integrates the cargo DNA into the zebrafish genome.

Advantages of Tol2

  • High Integration Efficiency: Tol2 can achieve highly efficient integration of transgenes and higher germline transmission rates than CRISPR/cas9.
  • Large Cargo Capacity: It can accommodate larger DNA fragments (up to 10kb), making it suitable for inserting substantial genetic constructs.
  • Fine Gene Expression Control: Rich promoter library availability.

Limitations of Tol2

  • Random Insertion: Unlike CRISPR/Cas9, Tol2 activity can not be directed to specific sites of the genome. The lack of locus-specific targeting makes the technique unsuitable for precise genetic modifications. Moreover, the random insertions of DNA sequences might occasionally lead to insertional mutagenesis and variable expression patterns.
  • Risk ofTransgene Silencing: although transgenes inserted via Tol2 tend to exhibit stable expression, there exists the risk of transgene silencing over generations.

Comparison and Applications

Both CRISPR/Cas9 and Tol2 have their strengths and weaknesses in zebrafish genome editing. CRISPR/Cas9 excels at precise, targeted modifications, making it ideal for studying gene function and creating disease models. Tol2, on the other hand,allows  generating stable transgenic lines and can accommodate larger cargo sizes.

In practice, researchers often combine these two techniques. CRISPR/Cas9 can be used to create knockout or knock-in lines, while Tol2 can be employed to generate transgenic reporters or overexpression constructs. This synergistic approach allows for the creation of complex genetic models with both targeted modifications and transgene expression.

In conclusion, both CRISPR/Cas9 and Tol2 are powerful tools for genome editing in zebrafish. The choice between the two depends on the specific research goals and the type of genetic modification required. By understanding the strengths and limitations of each technique, researchers can design more effective experiments and accelerate their zebrafish research projects.


[1] Anzalone, A.V., Koblan, L.W. & Liu, D.R. Genome editing with CRISPR-Cas nucleases, base editors, transposases, and prime editors. Nat Biotechnol 38, 824-844 (2020).

[2] Press release: The Nobel Prize in Chemistry 2020. Nobel Media AB 2020. Tue. 13 Oct 2020.

[3] Cornet, Carles et al. "Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline." Frontiers in pharmacology vol. 9 703. 3 Jul. 2018.

[4] Chang H. H. Y., Pannunzio N. R., Adachi N., Lieber M. R. (2017). Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat. Rev. Mol. Cell Biol. 18 495-506.

[5] Rafferty SA, Quinn TA. A beginner's guide to understanding and implementing the genetic modification of zebrafish. Prog Biophys Mol Biol. 2018 Oct;138:3-19.

[6] S. Albadri, F. Del Bene, C. Revenu Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish Methods, 121-122 (2017), pp. 77-85.

[7] K. Hoshijima, M.J. Jurynec, D.J. Grunwald Precise genome editing by homologous recombination Meth. Cell Biol., 135 (2016), pp. 121-147.

[8] H. Morita, K. Taimatsu, K. Yanagi, A. Kawahara Exogenous gene integration mediated by genome editing technologies in zebrafish Bioengineered, 8 (2017), pp. 287-295.

[9] A. Koga, M. Suzuki, H. Inagaki, Y. Bessho, H. Hori Transposable element in fish Nature, 383 (30) (1996).

[10] K. Kawakami, A. Shima, N. Kawakami Identification of a functional transposase of the Tol2 element, an Ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage Proc. Natl. Acad. Sci. Unit. States Am., 97 (2000), pp. 11403-11408.

[11] K.J. Clark, M.D. Urban, K.J. Skuster, S.C. Ekker Transgenic zebrafish using transposable elements Meth. Cell Biol., 104 (2011), pp. 137-149.

[12] J. Ni, K.J. Wangensteen, D. Nelsen, D. Balciunas, K.J. Skuster, M.D. Urban, S.C. Ekker Active recombinant Tol2 transposase for gene transfer and gene discovery applications Mobile DNA, 7 (2016).

[13] X. Chen, D. Gays, M.M. Santoro Transgenic zebrafish D. Ribatti (Ed.), Tumor Angiogenesis Assays: Methods and Protocols, Springer Science+Business Media (2016), pp. 107-114.

[14] Urasaki A, Morvan G, Kawakami K. Functional dissection of the Tol2 transposable element identified the minimal cis-sequence and a highly repetitive sequence in the subterminal region essential for transposition. Genetics. 2006;174:639-649.

[15] Kawakami K, Takeda H, Kawakami N, Kobayashi M, Matsuda N, Mishina M. A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Dev Cell. 2004;7:133-144.

[16] Amsterdam A, Lin S, Hopkins N. The Aequorea victoria green fluorescent protein can be used as a reporter in live zebrafish embryos. Dev Biol. 1995;171:123-129.

[17] Long Q, Meng A, Wang H, Jessen JR, Farrell MJ, Lin S. GATA-1 expression pattern can be recapitulated in living transgenic zebrafish using GFP reporter gene. Development. 1997;124:4105-4111.

Miriam-Martinez-ZeClinics By Miriam Martínez Navarro

Miriam is a Human Biologist expert in neuropharmacology. After a master’s degree in Pharmaceutical and Biotech Industry, she obtained her PhD in Biomedicine from Pompeu Fabra University (Barcelona). During her doctorate, she focused her research on the behavioral analysis of animal models for neurophenotypical characterization. Since then, she has been working in the healthcare marketing and publicity sector, where she has contributed to developing marketing campaigns for several pharmaceutical brands. In 2021, she joined ZeClinics with a branding and marketing strategy focus.

CRISPR/Cas9Disease modelingDisease modelsGene-editinggenetic modelsknock-inknock-outtarget validationtol2transgenic